As the role of physiotherapists continues to evolve, new opportunities are emerging for the profession to work to its full scope of practice. 

One area where this is already occurring is prescribing – in specific settings and locations, advanced practice physiotherapists are currently authorised to prescribe certain medications. 

Building on this potential, recent work being undertaken by the Physiotherapy Board of Australia and the APA aims to expand prescribing opportunities for appropriately qualified physiotherapists across a broader range of practice settings. 

An endorsement to enable physiotherapy prescribing has the potential to improve patient outcomes, enhance service efficiency and contribute to a more responsive and sustainable healthcare system. 

What does an endorsement for scheduled medicines for physiotherapy offer? 

The benefits of physiotherapy prescribing are well documented and extend beyond improving access to adequately trained health professionals who can prescribe. 

Physiotherapy prescribing supports a more holistic approach to patient management by allowing medication decisions to be integrated with rehabilitation, exercise, education and other non-pharmacological interventions. 

Physiotherapists commonly manage musculoskeletal conditions, pain, rehabilitation needs and chronic health issues, where medicines may form part of an overall treatment plan. 

Enabling appropriately trained physiotherapists to prescribe medicines within their scope of practice allows patients to receive more timely and coordinated care from a single practitioner. 

This reduces the need for multiple appointments with different clinicians, streamlines treatment pathways and can improve access to care, particularly in areas experiencing medical workforce shortages. 

For the profession, an endorsement represents an important evolution of physiotherapy practice. It acknowledges the growing expertise of physiotherapists in clinical assessment, decision-making and patient-centred care. 

An endorsement for scheduled medicines for the profession would enable physiotherapists to extend their practice, education and competence, strengthening their role as autonomous practitioners and valued members of multidisciplinary healthcare teams. 

What are we asking for? 

Some physiotherapists already have the authority to prescribe. 

However, these prescribing authorities are currently limited to advanced practice physiotherapists working in the public hospital sector. 

To fully utilise the capabilities of the physiotherapy workforce, practitioners across all areas of the healthcare system should have the opportunity to obtain prescribing rights, provided they meet the required standards, education levels and requirements. 

The Physiotherapy Board of Australia and the APA are developing a proposal for endorsement for suitably qualified registered Svitlana Romadina/Moment/via Getty Images physiotherapists. 

This would establish a nationally consistent framework to support physiotherapists’ use of scheduled medicines in practice and provide a clear pathway for endorsed practitioners. 

Where to from here? 

A proposal must go through a thorough risk assessment and consultations and be submitted to the health ministers. 

This proposal is currently being developed by the Physiotherapy Board of Australia. 

Following adequate consultation, the Ministerial Council will determine whether to approve the proposed endorsement. 

The APA will play a critical role in advancing this proposal through targeted advocacy, government engagement and stakeholder education. 

By championing the benefits of physiotherapy prescribing and highlighting the expertise of the profession, the APA will work to build support among decision-makers and help drive the reforms needed to expand prescribing opportunities for physiotherapists. 

It’s important to note that if approval is supported, it is a key milestone rather than the end of the process. 

Significant implementation work would still be required, including collaboration with states and territories to amend relevant legislation and ensuring that appropriate education and training pathways are available. 

Approval of the proposal also doesn’t mean that all physiotherapists would automatically be able to prescribe. 

Eligible practitioners would need to meet specific additional education, training and competency requirements before receiving an endorsement. 

The specifics of this are being developed and will be outlined in the proposal. 

While there is still a long way to go, this work represents an important step towards expanding prescribing rights and enabling physiotherapists to contribute even more effectively to patient care.